Share
Market Research Report

ANTI-MALARIAL DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug ClassAminoquinolines · Quinoline-methanol (4-quinolinemethanols) · Cinchona Alkaloids · Biguanides · Sulfonamides and Sulfones · and Others
  • By Route of AdministrationOral and Injectable
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • Published In31 Mar 2026
  • Report CodeCMI3726
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Class
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Product Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Anti-malarial Drugs Market, By Drug Class, 2021 - 2033 (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033(%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Aminoquinolines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Quinoline-methanol (4-quinolinemethanols)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Cinchona Alkaloids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Biguanides
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Sulfonamides and sulfones
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  5. Global Anti-malarial Drugs Market, By Route of Administration, 2021 - 2033 (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033(%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  6. Global Anti-malarial Drugs Market, By Distribution Channel, 2021 - 2033 (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033(%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  7. Global Anti-malarial Drugs Market, By Region, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033(%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
    • North America
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape

    • Company Profiles
      • Ipca Laboratories Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Zydus Group
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GSK plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cipla Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      •  Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Alvizia Health Care
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • F. Hoffmann-La Roche Ltd
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact